Researchers characterize three ways in which the gene FOXA1 mutates to trigger prostate cancer.
Cancer biologists and engineers collaborated on a device that could help predict the likelihood of breast cancer metastasis.
U-M researchers identify a potential treatment for non-alcoholic fatty liver disease.
Forty percent of people who develop venous thromboembolism don’t know what caused it. New research in mice further explores inflammation’s role.
Michigan-led research presents a new way of uncovering predictive biomarkers when data from large randomized trials aren’t available.
A 600-patient randomized clinical trial supports pembrolizumab and chemotherapy as a first-line treatment